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Adverse reactions are increasingly
reported for ultraviolet (UV) filters
used in sunscreens. We report the
third case in the literature of an
anaphylactic reaction after topical
application of a benzophenone-3-
containing sunscreen.
Case History
About 15 min after applying a sun-
screen (Sunspray SPF 15 water
resistant; Hegron Cosmetics, Pur-
merend, the Netherlands) all over
her body and before sun exposure,
a 44-year-old woman fainted with
generalized wheals, an inspiratory
stridor, low blood pressure (74/46
mmHg), and increased heart rate.
She required resuscitation with epi-
nephrine, dexamethasone, clemas-
tine, and saline and was transferred
to a hospital. Some months before,
she had experienced pruritus, ery-
thema, and nausea within 30 min of
putting on her bathing suit, which she
had also worn earlier while she
applied the sunscreen. She had used
the sunscreen previously without
apparent problem. She had no rele-
vant past history.
Patch testing with benzophenone-3
(10%pet.;Trolab,Hermal,Reinbek,
Germany) resulted in an urticarial
reaction at the test site within 20 min.
Patch tests with the European baseline
series (TRUE test; Mekos, Hillerød,
Denmark) and textile, cosmetic, and
perfume series were negative. Photo
patch tests (without benzophenone-3)
were negative. No specific immuno-
globulin E (IgE) antibodies were
found against inhalation allergens
or latex. An assay for detection of
IgE to benzophenone-3 was explored
by incubating benzophenone-3 with
human serum albumin immobilized
to caps followed by specific IgE
measurement (ImmunoCap; Phadia,
Uppsala, Sweden), but no specific




CAS number 131-57-7) has been
commonly used as a UV filter. In
the Netherlands, it was found in 49
of 162 (30%) tested samples of com-
mercial sunscreens (1). Benzophe-
none-3 was the most frequent cause
of photocontact allergy in several
reports. Other types of hypersensitiv-
ity reactions to it have been reported:
contact allergy, photocontact urti-
caria, and contact urticaria (2). Two
earlier cases of contact anaphylaxis
induced by benzophenone-3 have
been reported (3, 4).
Contact urticaria is divided into im-
munological and non-immunological
types. Non-immunological contact
urticaria is often less severe and does
not depend on specific IgE against the
substance. In our case, the severity of
the reaction and the observation that
hypersensitivity was acquired are
arguments to suggest an immunolo-
gical mechanism. The severity of the
clinical reaction experienced might
depend partly on the amount of skin
exposed to benzophenone-3; patch
testing did not elicit anaphylaxis in
our patient or in an earlier reported
case. Although IgE specific against
benzophenone-3 could not been
shown, the methodology is not reli-
able for benzophenone-3 as it is a small
lipophilic molecule and it is unknown
to what extent it was bound to the
caps; a positive control was lacking.
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